EMYRIA (ASX:EMD)
Who is EMYRIA (ASX:EMD)?
Emyria Limited is a clinical services and drug development company focused on improving patient outcomes in neuroscience and mental health via a unique business model: Emyria Care: Deliver evidence-based and emerging therapies for mental health and other unmet needs across multiple sites (Empax Ce...See more
Industry & Specialities
Healthcare
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
661 NEWCASTLE ST; LEEDERVILLE, WESTERN AUSTRALIA 6007, AU
Employees by Department
- IT / Product (2)
- Operations (1)
- The Rest (7)
- Total (10)
Key Decision Makers
Greg Hutchinson
Chairperson
Claudia Sullivan
Head of Clinical Governance
Tatjana Heinrich
Head of Preclinical Drug Development
Adrienne Smith
Project Manager, Special Projects
Employees by Seniority
C-level
3employees
Senior
0employees
Non-managers
3employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of EMYRIA (ASX:EMD)?
- Where is EMYRIA (ASX:EMD)'s headquarter?
- What EMYRIA (ASX:EMD)'s spending power?
- Does EMYRIA (ASX:EMD) have a presence in the domain it operates in?